Inhaled nitric oxide inhibits platelet-leukocyte interactions in patients with acute respiratory distress syndrome

Critical Care Medicine

Volumn 31, Issue 6, 2003, Pages 1697-1704

  Gries, André ^a   Herr, Axel ^a   Kirsch, Sylvia ^a   Günther, Christine ^a   Weber, Steffen ^a   Szabo, Gabor ^a   Holzmann, Alexandra ^a   Böttiger, Bernd W ^a   Martin, Eike ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acute respiratory distress syndrome; Inhaled nitric oxide; Leukocytes; Platelets

Indexed keywords

CELL SURFACE RECEPTOR; FIBRINOGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NITRIC OXIDE; PADGEM PROTEIN;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIGEN EXPRESSION; ARTICLE; ARTIFICIAL VENTILATION; CELL AGGREGATION; CELL INTERACTION; CLINICAL ARTICLE; FEMALE; FIBRINOGEN BINDING; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; MALE; OXYGENATION; PLATELET LEUKOCYTE AGGREGATION; PLATELET LEUKOCYTE INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RESPIRATORY DISTRESS; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, CD11A; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; NITRIC OXIDE; P-SELECTIN; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; RECEPTORS, IMMUNOLOGIC; RESPIRATORY DISTRESS SYNDROME, ADULT; STATISTICS, NONPARAMETRIC;

EID: 0038806343     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000063446.19696.D3     Document Type: Article

References (51)

1. Dellinger RP, gimmermann JL, Taylor RW, et al: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Inhaled nitric oxide in ARDS study group. Crit Care Med 1998; 26:15-23
2. Ullrich R, Lorber C, Roder G, et al: Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS. Anesthesiology 1999; 91:1577-1586
3. Samama CM, Diaby M, Fellahi JL, et al: Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1995; 83:56-65
4. Gries A, Bode C, Peter KH, et al: Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation 1998; 97:1481-1487
5. Gauthier TW, Davenpeck KL, Lefer AM: Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol 1994; 267:G562-G568
6. Bloomfield GL, Sweeney LB, Fisher BJ, et al: Delayed administration of inhaled nitric oxide preserves alveolar-capillary membrane integrity in porcine gram-negative sepsis. Arch Surg 1997; 132:65-75
7. Sato E, Simpson KL, Grisham MB, et al: Reactive nitrogen and oxygen species attenuate interleukin-8 - induced neutrophil chemotactic activity in vitro. J Biol Chem 2000; 275:10826-10830
8. Lee Ch, Miura K, Liu X, et al: Biphasic regulation of leukocyte superoxide generation by nitric oxide and peroxynitrite. J Biol Chem 2000; 275; 38965-38972
9. Okabayashi K, Triantafillou AN, Yamashita M, et al: Inhaled nitric oxide improves lung allograft function after prolonged storage. J Thorac Cardiovasc Surg 1996; 112:293-299
10. Kanwar S, Kubes P: Nitric oxide is an anti-adhesive molecule for leukocytes. New Horiz 1995; 3:93-104
11. Malmros C, Blomquist S, Dahm P, et al: Nitric oxide inhalation decreases pulmonary platelet and neutrophil sequestration during extracorporeal circulation in the pig. Crit Care Med 1996; 24:845-849
12. Celi A, Lorenzet R, Furie B, et al: Platelet-leukocyte-endothelial cell interaction on the blood vessel wall. Semin Hematol 1997; 34: 327-335
13. Evangelista V, Manarini S, Sideri R, et al: Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion. Role of PSGL-1 as a signaling molecule. Blood 1999; 93:876-885
14. Eichacker PQ: Inhaled nitric oxide in adult respiratory distress syndrome: Do we know the risks versus benefits? Crit Care Med 1997; 25:563-565
15. Smith P: NO: Good or not? Crit Care Med 1999; 27:1059-1060
16. Adrie C, Bloch KD, Moreno PR, et al: Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation 1996; 94:1919-1926
17. Szabo G, Batkai S, Baehrle S, et al: Effects of nitric oxide synthesis on reperfusion injury and catecholamine responsiveness in a heterotopic rat heart transplantation model. J Cardiovasc Pharmacol 1998; 31:221-230
18. Yodice P, Astiz M, Kurian B, et al: Neutrophil rheologic changes in septic shock. Am J Respir Crit Care Med 1997; 155:38-42
19. Weiland JE, Davis WB, Holter JF, et al: Lung neutrophils in the adult respiratory distress syndrome: Clinical and pathophysiological significance. Am Rev Respir Dis 1986; 133:218-225
20. Chollet-Martin S, Gatecel C, Kermarrec N, et al: Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med 1996; 153:985-990
21. Nussler A, Wittel U, Nussler N, et al: Leukocytes, the janus cells in inflammatory disease. Langenbeck's Arch Surg 1999; 384:222-232
22. Bernard GR, Artigas A, Brigham KL, et al: The American-European consensus conference on ARDS: Definitions, mechanisms, relevant out-comes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
23. Li N, Goodall AH, Hjemdahl P: Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry 1999; 35:154-161
24. Xiao Z, Theroux P, Frojmovic M: Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor. Thromb Haemost 1999; 81:281-285
25. Gries A, Herr A, Motsch J, et al: Randomized, placebo-controlled, blinded and cross-matched study on the antiplatelet effect of inhaled nitric oxide in healthy volunteers. Thromb Haemost 2000; 83:309-315
26. Gries A, Bode C, Peter KH, et al: Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation 1998; 97:1481-1487
27. Tarnok A, Bocsi J, Roessler H, et al: Low degree of activation of circulating neutrophils determined by flow cytometry during cardiac surgery with cardiopulmonary bypass. Cytometry 2001; 46:41-49
28. Frenette PS: Locking a leukocyte integrin with statins. N Engl J Med 2001; 345:1419-1421
29. McEver RP: Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001; 86:746-756
30. Rainger GE, Buckley C, Simmons DL, et al: Neutrophils rolling on immobilised platelets migrate into homotypic aggregates after activation. Thromb Haemost 1998; 79:1177-1183
31. Kirton CM, Nash GB: Activated platelets adherent to an intact endothelial cell monolayer bind flowing neutrophils and enable them to transfer to the endothelial surface. J Lab Clin Med 2000; 136:303-313
32. Gardinali M, Borrelli E, Chiara O, et al: Inhibition of CD11-CD18 complex prevents acute lung injury and reduces mortality after peritonitis in rabbits. Am J Respir Crit Care Med 2000; 161:1022-1029
33. Kosonen O, Kankaanranta H, Malo-Ranta U, et al: Nitric oxide releasing compounds inhibit neutrophil adhesion to endothelial cells. Eur J Pharmacol 1999; 382:111-117
34. Chello M, Mastroroberto P, Marchese AR, et al: Nitric oxide inhibits neutrophil adhesion during experimental extracorporeal circulation. Anesthesiology 1998; 89:443-448
35. Fox Robichaud A, Payne D, Kubes P: Inhaled NO reaches distal vasculatures to inhibit endothelium- but not leukocyte-dependent cell adhesion. Am J Physiol 1999; 277:L1224-L1231
36. Opdahl H, Haugen T, Hagberg IA, et al: Effects of short-term nitrogen monoxide inhalation on leukocyte adhesion molecules, generation of reactive oxygen species, and cytokine release in human blood. Nitric Oxide 2000; 4:112-122
37. Fox-Robichaud A, Payne D, Hasan SU, et al: Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 1998; 101:2497-2505
38. Hasleton PS, Roberts TE: Adult respiratory distress syndrome: An update. Histopathology 1999; 34:285-294
39. Lopes AA, Maeda NY, Almeida A, et al: Circulating platelet aggregates indicative of in vivo platelet activation in pulmonary hypertension. Angiology 1993; 44:701-706
40. Li N, Wallen NH, Hjemdahl P: Evidence for prothrombotic effects of exercise and limited protection by aspirin. Circulation 1999; 100:1374-1379
41. Hamburger SA, Mc Ever RP: GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75:550-554
42. Rinder HM: Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991; 78:1730-1737
43. Langford EJ, Wainwright RJ, Martin JF: Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol 1996; 16:51-55
44. Keh D, Gerlach M, Kurer I, et al: Nitric oxide diffusion across membrane lungs protects platelets during simulated extracorporeal circulation. Eur J Clin Invest 1999; 29:344-350
45. Rinder CS, Bonan JL, Rinder HM, et al: Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79:1201-1207
46. Gawaz MP, Mujais SK, Schmidt B, et al: Platelet-leukocyte aggregates during hemodialysis: Effect of membrane type. Artif Organs 1999; 23:29-36
47. Gawaz M, Fateh-Moghadam S, Pilz G, et al: Platelet activation and interaction with leukocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 1995; 25:843-851
48. Kurose I, Wolf R, Grisham MB, et al: Effects of endogenous inhibition of nitric oxide synthesis on postcapillary venules. Am J Physiol 1995; 268:H2224-H2231
49. De La Cruz JP, Blanco E, Sanchez de la Cuesta F: Effects of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway. Eur J Pharmacol 2000; 397:35-41
50. Jilma B, Hergovich N, Stohlawetz P, et al: Effects of sodium nitroprusside on hemodialysis-induced platelet activation. Kidney Int 1999; 55:686-691
51. Christenson J, Lavoie A, O'Connor M, et al: The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med 2000; 161:1443-1449